 Home > Medical News >

Medical Research Articles

FDA grants AstraZeneca's new anti-inflammatory drug, Fasenra (benralizumab), as an orphan drug for HES

 Time of Update: 2020-06-10

albumin drug valium drug aspirin drug anti gas pills sudafed drug class

recently, AstraZeneca, the giant of pharmaceutical (http:// in the UK, announced that the Authority for food and drugs (http:// had granted the new anti-inflammatory drug Fasenra (http:// a n
FDA accepts and grants priority review of new drug application for first-third-in-a-nation pexidartinib

 Time of Update: 2020-06-10

pharmaceutical company zyrtec drug cartia drug drug test patch frog drug

recently, Daiichi Sankyo, a Japanese pharmaceutical company, announced that the u.S Food and Drug (http:// Administration ( FDA (http:// ) had accepted the new drug (http:// application for
NICE approves euthanrhus anti-inflammatory drug Cimzia (certolizumab pegol) for treatment of adult patients with plaque psoriasis

 Time of Update: 2020-06-10

anti factor xa systemic inflammatory disease steroids anti inflammatory rheumatoid arthritis prevention anti tnf alpha

recently, the National Institute scare spree (NICE) approved the UCB anti-inflammatory drug Cimzia (certolizumab pegol) for the treatment of adult patients with severe plaque psoriasis who have no r
Phase 1b clinical trial of AOBiome provides B244 treatment for first young patient

 Time of Update: 2020-06-10

ptu side effects high capacity scale clbp medical abbreviation microbiome skin phase modulation

AOBioMes, Inc ("AOBiome), a leading clinical stage microbiotic development focused on innovative treatments for skin diseases, migraines, hypertension and other systemic diseases (http:// , today
FDA approves Inbrija (Left-handed Doba Inhalation Powder) for treatment of Parkinson's disease

 Time of Update: 2020-06-10

florida citrus disease disease phenotype powder alzheimer's disease test huntington's disease mri

recently, Acorda Therapeutics (http:// announced that the key Phase III efficacy study spanSM-PD (NCT02240030) for the treatment of Patients with Parkinson's disease (PD) in Inbrija (Left-handed
Baiotai BioBAT1806 (Tozhu monoantigen) Global Phase III clinical study has completed the first patient administration

 Time of Update: 2020-06-10

randomized controlled study rinchem company inc sterling company electricity united states zolpidem generic name

recently, BaiotaI Biotech (Guangzhou) Limited Company (http:// announced that the company has completed its first patient administration in the global clinical study of the bio- pharmaceutical
Johnson and Johnson announces FDA approval for new drug application for Opsumit

 Time of Update: 2020-06-10

use salicylic acid 4 bubble letter beetlejuice treatment use witch hazel program

recently, Actelion http:// , a company owned by Pharmaceutical s (http:// jndJ) , announced that the http:// application for the of the new drug (http:// of The http:// had received a comple
FDA approves Sage's Zulresso injection storapy for postpartum depression

 Time of Update: 2020-06-10

drug delivery system fda approved products ibuprofen active ingredient food sickness symptoms food eat pregnancy

PPD is a clear and easily identifiable form of severe depression, a common birth complication that affects some pregnant women and usually occurs late in pregnancy or within 4 weeks of childbirth r
FDA approves Astellas Xospatinib for treatment in adult patients with acute myeloid leukemia

 Time of Update: 2020-06-10

rose blood geometric growth rate factor 8 blood spss data analysis science based health

recently, Japanese drugmaker Astellas announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved Xosopa (gilteritinib) for the treatment of patients with recurren
FDA grants Promedior Inc. to study antififistosis immunomodulator PRM-151 breakthrough therapy

 Time of Update: 2020-06-10

liver fibrosis reversible rare types bone diseases distance pfizer rare disease

today, Promedior (http:// announced that the U.S FDA (http:// granted the company's pre-development anti-fibromy immunomodulator PRM-151 breakthrough therapy for the treatment of iasevere pulm
FDA grants Bacchishents BTK inhibitorzanubrutinib breakthrough therapy designation

 Time of Update: 2020-06-10

drug interactions list guide drug combinations horizant drug stemi nstemi treatment naltrexone drug class

lymphoma is a group of malignant tumors with multiple subtypes that originate in B, T or NK cells Set cell lymphoma (MCL) is usually an invasive non-Hodgkin's lymphoma (NHL) that originates from B c
MHLW approves Gilead's three-in-one new drug Biktarvy for treatment of HIV-1 infection

 Time of Update: 2020-06-10

type food list black light box guanfacine 2 mg black 2.0 paint ketamine adverse reactions

recently, the U.S Pharmaceutical (http:// giant Gilead announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the three-in-one new drug (http:// biktarvy for the tre
UCB Japan Co and First Third Co Pharmaceuticals jointly announce Vimpat ® intravenous 200mg has been launched in Japan

 Time of Update: 2020-06-10

trulicity drug class suboxone drug class thermal control products senna drug class alendronate sodium take

recently, the Belgian Pharmaceutical (http:// giant UCB Japan sub- company (http:// UCB Japan Co and First Third Pharmaceuticals announced that Vimpat ® intravenous infusion 200mg (generic nam
CHMP recommends approval of pharmaceutical besremi for the treatment of asymptomatic spleen enlargement and real erythrophaemia

 Time of Update: 2020-06-10

famotidine side effects blood cell chart melarsomine side effects faslodex side effects lupus side effects

recently, Pharmaceutical Pharmaceutical (http:// limited shares company (http:// (http:// announced that the human medicine product seine (http:// Committee (CHMP) adopted a positive opinio
Cinda BioOX40 monoclonal antibody (IBI101) has been approved by FDA-issued drug clinical trials

 Time of Update: 2020-06-10

hrp antibody types anti inflammatory drugs mdna drug reference anti hiv medication anti rex 3000

today, Cinda Bio Pharmaceutical (http:// (Hong Kong Stock Exchange Code: 01801) announced that it has developed a recombinant whole-human source anti-tumor necrosis receptor hyperfamily member 4
European Commission approves vaccine Flucelvax for Tetra 9 and older

 Time of Update: 2020-06-10

dendritic cell vaccine universal flu vaccine company safety flu vaccine eggs united states electricity

recently, (http:// a company owned by the Australian Bio Pharmaceutical (http:// , announced Seqirus, the European Commission, that the European Commission had approved the fluixelvax Tetra for
FDA approves Olapa's first-line maintenance treatment for BRCA mutation in advanced ovarian cancer

 Time of Update: 2020-06-10

imdur 30 mg dna study 1 2 addition fastest dna test lohmann therapy systems

December 19, 2018, AstraZeneca and Mercado jointly announced that the U.S Food and Drug (http:// Regulatory Authority ( FDA (http:// ) has approved Olapa's use of harmful or suspected harmful re
European Commission approves Meropinan/vaborbactam treatment for adult patients with incurable infectious diseases

 Time of Update: 2020-06-10

levaquin drug class tiotropium drug class escherichia coli infection coli strains warfarin toxicity treatment

November 20, 2018, the European Commission approved the clinical application of Meropinan/vaborbactam to treat adult patients with difficult-to-cure infectious diseases And more recently, the Menar
Alkermes' treatment of schizophrenia reaches common primary endpoint in clinical trial of the drug ALKS 38313

 Time of Update: 2020-06-10

2 4 hexadiene lynparza side effects empagliflozin side effects mestinon side effects rigid insulation weight

schizophrenia, a serious chronic chronic deactivation brain disease The main symptoms of the disease include hallucinations, delusions, depression, emotional retardation, social withdrawal, and ment
Xi'an Yangsen's Zei yu ® (Acetate Abitron tablets) new indications approved by the State Drug Administration

 Time of Update: 2020-06-10

all red 4 amyl nitrate drug 3 8 7 8 all ds what co 2

prostate cancer is the most common urogenital cancer in Chinese men, with a national incidence rate of 9.8 per 100,000 people and a high rate of 12.07 percent per year yesterday (December 4), Johns

Go to Page

Medical Research Articles

FDA grants AstraZeneca's new anti-inflammatory drug, Fasenra (benralizumab), as an orphan drug for HES

FDA accepts and grants priority review of new drug application for first-third-in-a-nation pexidartinib

NICE approves euthanrhus anti-inflammatory drug Cimzia (certolizumab pegol) for treatment of adult patients with plaque psoriasis

Phase 1b clinical trial of AOBiome provides B244 treatment for first young patient

FDA approves Inbrija (Left-handed Doba Inhalation Powder) for treatment of Parkinson's disease

Baiotai BioBAT1806 (Tozhu monoantigen) Global Phase III clinical study has completed the first patient administration

Johnson and Johnson announces FDA approval for new drug application for Opsumit

FDA approves Sage's Zulresso injection storapy for postpartum depression

FDA approves Astellas Xospatinib for treatment in adult patients with acute myeloid leukemia

FDA grants Promedior Inc. to study antififistosis immunomodulator PRM-151 breakthrough therapy

FDA grants Bacchishents BTK inhibitorzanubrutinib breakthrough therapy designation

MHLW approves Gilead's three-in-one new drug Biktarvy for treatment of HIV-1 infection

UCB Japan Co and First Third Co Pharmaceuticals jointly announce Vimpat ® intravenous 200mg has been launched in Japan

CHMP recommends approval of pharmaceutical besremi for the treatment of asymptomatic spleen enlargement and real erythrophaemia

Cinda BioOX40 monoclonal antibody (IBI101) has been approved by FDA-issued drug clinical trials

European Commission approves vaccine Flucelvax for Tetra 9 and older

FDA approves Olapa's first-line maintenance treatment for BRCA mutation in advanced ovarian cancer

European Commission approves Meropinan/vaborbactam treatment for adult patients with incurable infectious diseases

Alkermes' treatment of schizophrenia reaches common primary endpoint in clinical trial of the drug ALKS 38313

Xi'an Yangsen's Zei yu ® (Acetate Abitron tablets) new indications approved by the State Drug Administration